Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb:49:87-92.
doi: 10.1016/j.breast.2019.11.002. Epub 2019 Nov 11.

Mucinous breast cancer: A narrative review of the literature and a retrospective tertiary single-centre analysis

Affiliations
Review

Mucinous breast cancer: A narrative review of the literature and a retrospective tertiary single-centre analysis

Emilia Marrazzo et al. Breast. 2020 Feb.

Abstract

Mucinous carcinoma (MC) is a rare breast cancer characterized by the presence of large extracellular mucin amount. Two main subtypes can be distinguished: pure (PMC) and mixed (MMC). We conducted a retrospective MC analysis in our prospective maintained database, calculating disease-free survival (DFS) and 5-year overall survival (OS). We found a global 92.1% OS (higher in MMC group and statistically significative) and a DFS of 95.3% (higher in MMC group but not statistically significative).

Keywords: Adenocarcinoma. background; Breast; Breast cancer; Breast conserving surgery; Breast neoplasms; Breast surgery; Epidemiology; Invasive breast cancer; Mastectomy; Mucinous carcinoma.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no conflict of interest in relation to this work.

Figures

Fig. 1
Fig. 1
Overall Survival rate of PMC and MMC.
Fig. 2
Fig. 2
Disease Free Survival rate of PMC and MMC.

References

    1. Bae S.Y., Choi M.Y., Cho D.H., Lee J.E., Nam S.J., Yang J.H. Mucinous carcinoma of the breast in comparison with invasive ductal carcinoma: clinicopathologic characteristics and prognosis. J Breast Cancer. 2011;14:308–313. - PMC - PubMed
    1. Hanagiri T., Ono K., Baba T., So T., Yamasaki M., Nagata Y. Clinicopathologic characteristics of mucinous carcinoma of the breast. Int Surg. 2010;95:126–129. - PubMed
    1. Kashiwagi S., Onoda N., Asano Y., Noda S., Kawajiri H., Takashima T. Clinical significance of the sub-classification of 71 cases mucinous breastcarcinoma. SpringerPlus. 2013;2:481. - PMC - PubMed
    1. Komaki K., Sakamoto G., Sugano H., Morimoto T., Monden Y. Mucinous carcinoma of the breast in Japan. A prognostic analysis based on morphologic features. Cancer. 1988;61:989–996. - PubMed
    1. Lakhani S.R., Ellis I.O., Schnitt S.J., Tan P.H., van de Vijver M.J. World health organization classification of tumours. fourth ed. International Agency for Research on Cancer; Lyon: 2012. WHO classification of tumours of the breast; pp. 60–61.

MeSH terms